Imara Reports Full Year 2020 Financial Results and Business Highlights
Significant progress advancing IMR-687 as an oral, once-a-day potentially disease modifying treatment for sickle cell…
Significant progress advancing IMR-687 as an oral, once-a-day potentially disease modifying treatment for sickle cell…
WARREN, N.J., March 05, 2021 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical…
— Company to host conference call on March 9th, 2021, at 8:00 a.m. ET —…
ORION CORPORATION MANAGERS’ TRANSACTIONS 5 MARCH 2021 at 11.00 EET Orion Corporation: Managers’ transactions…
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. PUBLICATION RELATING TO A TRANSPARENCY NOTIFICATION (ARTICLE 14, 1ST PARAGRAPH,…
Company announcement, Helsinki, 5 March 2021 at 09.00 am (EET) Nexstim Plc Publishes 2020 Annual…
The knee bandage with the name Caresole Circa Knee can basically be worn by every…
Phase III trial patient enrollment for balixafortide completed in Q4 2020 despite COVID-19. Results expected…
SAN DIEGO, March 04, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), announced…
-Yselty® for uterine fibroids: US New Drug Application filing planned in Q2:21; European marketing approval…